Marco Niedergethmann

8.2k citations
68 papers · 4.8k indexed · 2 hit papers · h-index 24
Topics
Pancreatic and Hepatic Oncology Research (36 papers)Pancreatitis Pathology and Treatment (18 papers)Neuroendocrine Tumor Research Advances (17 papers)

In The Last Decade

Marco Niedergethmann

61 papers receiving 4.7k citations

Hit Papers

Adjuvant Chemotherapy With Gemcitabine vs Observation in ...20072026201320192007201350010001.5k

Peers

Marco Niedergethmann
Comparison fields: 5 of 96
  • Oncology 4.3k
  • Surgery 2.2k
  • Pulmonary and Respiratory Medicine 1.5k
  • Epidemiology 1.4k
  • Cancer Research 1.2k
Replace F. Huguet with:
F. Huguet France
John C. Mansour United States
Linus Ho United States
Ángela Lamarca United Kingdom
Sarah E. Hoffe United States
Harald Schmalenberg Germany
H. Au Canada
Ching‐Wei D. Tzeng United States
Amy M. Fremgen United States
Ronald R. Salem United States
Marco Niedergethmann relative to F. Huguet France F. Huguet's profile →
Citations per field
00.5×
F. Huguet · 1×
Citations per year

Countries citing papers authored by Marco Niedergethmann

Since Specialization
Citations

This map shows the geographic impact of Marco Niedergethmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Niedergethmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Niedergethmann more than expected).

Fields of papers citing papers by Marco Niedergethmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Niedergethmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Niedergethmann. The network helps show where Marco Niedergethmann may publish in the future.

Co-authorship network of co-authors of Marco Niedergethmann

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Niedergethmann. A scholar is included among the top collaborators of Marco Niedergethmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Niedergethmann. Marco Niedergethmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 13
4 18
5 4
6 2
7 3
8 2
9 10
10 23
11 52
12 5
13 39
14
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancerbreakdown →
1754
15 23
16 166
17 44
18 65
19 2
20 5

About Marco Niedergethmann

Marco Niedergethmann is a scholar working on Oncology, Surgery and Cancer Research, having authored 68 papers that have together received 4.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (36 papers), Pancreatitis Pathology and Treatment (18 papers) and Neuroendocrine Tumor Research Advances (17 papers). The work is most often cited by research in Oncology (4.3k citations), Cancer Research (1.2k citations) and Surgery (2.2k citations). Marco Niedergethmann has collaborated with scholars based in Germany, China and United States. Frequent co-authors include Stefan Post, Helmut Oettle, Hanno Riess, Klaus Gellert, P. Neuhaus, Karsten Ridwelski, Α. Richter, Marianne Sinn, Andreas Hochhaus and C. Zülke. Their work appears in journals such as JAMA, Journal of Clinical Oncology and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026